AML (Acute Myeloid Leukemia),Leukemia FLT3‑ITD– Specific MRD Clearance Improves OS In FLT3-ITD+ AML Patients Nov 06, 2023
AML (Acute Myeloid Leukemia),Leukemia Quizartinib Extends OS In FLT3-ITD + AML Irrespective Of Allo-HCT In CR1 Oct 17, 2023
AML (Acute Myeloid Leukemia),Leukemia Venetoclax-FLAI Improves Survival in Intermediate/High-Risk AML Oct 09, 2023
AML (Acute Myeloid Leukemia),Leukemia Standard Chemo + Quizartinib Vs. Placebo In Newly Diagnosed FLT3-ITD WT AML Patients Oct 03, 2023
AML (Acute Myeloid Leukemia),Leukemia Combined Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome Sep 29, 2023
AML (Acute Myeloid Leukemia) FLT3 Inhibitor Gilteritinib Trial for Post-Transplant Maintenance in FLT3-ITD AML Sep 19, 2023